AVX101

BIOLOGICAL2 trials

Sponsors

AlphaVax, Inc.

Conditions

HIV Infections

Phase 1

Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa

CompletedNCT00063778

AlphaVax, Inc.HIV Infections

Start: 2003-07-31End: 2005-07-31Updated: 2012-07-02

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

CompletedNCT00097838

AlphaVax, Inc.HIV Infections

Start: 2004-10-31End: 2009-09-30Updated: 2012-07-02